Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Name Transcript

Operator

Good morning, and welcome to the Lucid Diagnostics Third Quarter 2025 Enterprise Replace Convention Name. Please observe, this occasion is being recorded.

I might now like to show the convention over to Matt Riley, Director, Investor Relations. Please go forward, sir.

Matthew Riley
Director of Investor Relations

Thanks, operator, and good morning, everybody. Thanks for collaborating in at present’s enterprise replace name. Becoming a member of me at present on the decision are: Dr. Lishan Aklog, Chairman and CEO of Lucid Diagnostics; together with Dennis McGrath, CFO. The press launch saying our enterprise replace and monetary outcomes is on the market on Lucid’s web site. Please take a second to learn the disclaimers about forward-looking statements within the press launch.

The enterprise replace press launch and the convention name all embody forward-looking statements, and these forward-looking statements are topic to recognized and unknown dangers and uncertainties that will trigger precise outcomes to vary materially from statements made. Components that would trigger precise outcomes to vary are described within the disclaimer and in our filings with the SEC. For an inventory and outline of those and different vital dangers and uncertainties that will have an effect on future operations, see Half 1, Merchandise 1A entitled Danger Components in Lucid’s most up-to-date annual report on Kind 10-Ok filed with the SEC and any subsequent updates filed in quarterly experiences on Varieties 10-Q and subsequent Varieties 8-Ok.